Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been
associated with a high incidence of arterial and venous thrombotic complications. However …

BACKGROUND The hypercoagulable state associated with coronavirus disease 2019
(COVID-19) has been shown to complicate the course of this viral illness with both venous …

Since the outbreak of the COVID-19 pandemic, thrombotic events have been accurately
described in patients infected by the SARS-CoV-2, especially venous thromboembolism …

Thromboembolic manifestations like pulmonary embolism and deep venous thrombosis are
often reported and contribute to a significant mortality from acute and chronic COVID-19 …

Abstract The coronavirus disease 2019 (COVID-19) disease is a multisystem disease and
recent studies have shown an increase in reported thromboembolic complications as deep …

COVID-19 infection has been associated with thrombotic complications, especially venous
thromboembolism. Although arterial thrombotic complications are rarely seen in these …

Abstract Coronavirus disease-2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and represents a potentially fatal disease. COVID …

Abstract Background Coronavirus disease 2019 (COVID-19) is identified as the pneumonia
and acute respiratory distress syndrome caused by severe acute respiratory syndrome …

A high incidence of thromboembolic events and coagulation parameter abnormalities are
seen in cases of coronavirus disease 2019 (COVID-19). Both venous and arterial …

Since the outbreak of the COVID-19 pandemic, increasing evidence suggests that infected
patients present a high incidence of thrombotic complications. This report describes 4 cases …